Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1993;73:3-9

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robbins, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robbins, J.

Circulation Research, Vol 73, 3-9, Copyright © 1993 by American Heart Association


ARTICLES

Gene targeting. The precise manipulation of the mammalian genome

J Robbins
Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, OH 45267-0575.

Genetics is a powerful tool for studying the function of different gene products as well as the physiological consequences of a normal or aberrant polypeptide. Until recently, the most powerful genetic applications have been restricted to relatively simple organisms whose genomes are more easily manipulated. For a number of years, in lower organisms, it has been possible to create defined genetic changes that are targeted to a specific locus or even to a defined codon or transcriptional regulatory sequence. With the development of gene targeting using embryonic stem cells derived from the preimplantation blastocyst of a mouse, it has become possible to extend these experiments to a mammalian system. Via homologous recombination, one can ablate, or "knock out," a defined genetic locus or mutate a particular set of nucleotides that encodes a peptide domain of interest. These techniques, when applied to genes that underlie normal cardiovascular function, promise to define the exact role(s) different proteins play during the development, growth, and maintenance of the heart. The ability to generate defined animal models of human disease in which the primary genetic defect is known should lead to fundamental advances in the study of the normal and failing heart.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J Hescheler, B.K Fleischmann, S Lentini, V.A Maltsev, J Rohwedel, A.M Wobus, and K Addicks
Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis
Cardiovasc Res, November 1, 1997; 36(2): 149 - 162.
[Full Text] [PDF]


Home page
HypertensionHome page
P. Wiesel, L. Mazzolai, J. Nussberger, and T. Pedrazzini
Two-Kidney, One Clip and One-Kidney, One Clip Hypertension in Mice
Hypertension, April 1, 1997; 29(4): 1025 - 1030.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
Z. Yu, C. S. Redfern, and G. I. Fishman
Conditional Transgene Expression in the Heart
Circ. Res., October 1, 1996; 79(4): 691 - 697.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M.P. Davies, R.H. An, P. Doevendans, S. Kubalak, K.R. Chien, and R.S. Kass
Developmental Changes in Ionic Channel Activity in the Embryonic Murine Heart
Circ. Res., January 1, 1996; 78(1): 15 - 25.
[Abstract] [Full Text]


Home page
CirculationHome page
V. J. Dzau, G. H. Gibbons, B. K. Kobilka, R. M. Lawn, and R. E. Pratt
Genetic Models of Human Vascular Disease
Circulation, January 15, 1995; 91(2): 521 - 531.
[Abstract] [Full Text]